Key terms
About Amgen Inc. 4.0% 13-SEP-2029
Sector
Health Technology
Industry
Biotechnology
Home page
Identifiers
2
ISIN XS0829324457
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
Related bonds
Sign up to see advanced bond data
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.